In a follow-up to last year's media report, the Association of National Advertisers details "dysfunction" and rigged bids.
Biogen reports better-than-expected Spinraza sales; FDA to discuss opioid prescriptions with payers; UnitedHealth Group launches media review
In apportioning their media budgets, pharma companies continue to straddle the line between new and traditional strategies.
Drugmakers are becoming much more cautious with their budgets, WebMD executives said.
WPP's acquisition of CMI, a significant player in the healthcare media-planning space, will likely bolster the services it provides to pharma clients.
Interpublic's dedicated group extended its brief beyond North America.
The agency plans to use health outcomes data to better inform pharmaceutical marketing strategies.